ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona
Johnson & Johnson at ESMO 2026
Oct 23–27, 2026 Madrid, Spain ~37k attendees Website
Johnson & Johnson takes part in 4 sessions at ESMO 2026 in Madrid, and exhibits at Booth 1029. Its program centres on personalized cancer treatment, quality of life and precision care in prostate and lung cancers. Topics include data sources for prostate cancer DNA-repair mutations and coordinated care for lung cancer with EGFR mutations.
| Organization | ESMO 2026 Attendance |
|---|---|
Healthcare company whose Innovative Medicine business markets oncology drugs including amivantamab, daratumumab and teclistamab. | Booth Exhibiting at Booth 1029 · Johnson & Johnson Innovative Medicine Poster Fri Oct 23 13:00–15:00 Identifying and assessing fit-for-use real-world data sources for homologous recombination repair mutations in prostate cancer: A systematic literature review supplemented by artificial intelligence Genitourinary cancersBiomarkers & precision oncology Satellite Fri Oct 23 18:15–19:45 Satellite Sat Oct 24 14:00–15:30 J&J - Collaborative Precision Care in EGFR-mutated NSCLC. A Multidisciplinary Approach Lung & thoracic cancersNursing & supportive care Satellite Sun Oct 25 13:00–14:30 Johnson & Johnson - Transforming the Treatment Journey in EGFR- Mutant NSCLC Lung & thoracic cancers |
Find decision makers at Johnson & Johnson
Tell us what you sell and we’ll find the people at Johnson & Johnson most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction